Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CytoMed Therapeutics Limited - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GDTC
Nasdaq
2834
w2.cytomed.sg
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CytoMed Therapeutics Limited
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Oct 9th, 2026 2:30 pm
CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects
- Feb 6th, 2026 11:05 am
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
- Jan 29th, 2026 8:11 am
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
- Jan 28th, 2026 8:00 am
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
- Jan 13th, 2026 6:00 am
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
- Dec 8th, 2025 6:00 am
Scroll